Heart Failure Clinical Trial

Comparing Diuretic Strategies in Hospitalized Heart Failure

Summary

We will conduct a pragmatic randomized trial comparing whether using a combination of two types of diuretics (loop + thiazide) compared with using a single diuretic (loop only) will result in shorter hospital stays for patients hospitalized with heart failure.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Any adult (age ≥18 years) admitted to the Heart Failure Service at Stanford Health Care with an indication for treatment with a diuretic.

Exclusion Criteria:

admission to the intensive care unit or cardiac care units
maintenance dialysis on admission
any mechanical circulatory support on admission
history of heart transplant
allergy / intolerance to loop or thiazide diuretics
admission serum sodium < 125 meq/L (from EPIC)
admission serum potassium < 3.0 meq/L (from EPIC)

Study is for people with:

Heart Failure

Phase:

Phase 4

Study ID:

NCT03999216

Recruitment Status:

Withdrawn

Sponsor:

Stanford University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Stanford Health Care
Palo Alto California, 94304, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Phase:

Phase 4

Study ID:

NCT03999216

Recruitment Status:

Withdrawn

Sponsor:


Stanford University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider